A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Clinical trial NCT04546399 · RECRUITING
Trial details
- NCT number
- NCT04546399
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-17
- Primary completion
- 2028-06-30
- Enrollment
- 461
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.